Clin2
NCT06749470Possibly a fitNot yet recruiting

Jieyu Chufan Capsules for Depression Treatment

Major Depressive Disorder (MDD)

Part of Mental health clinical trials.

This trial tests whether a traditional Chinese medicine capsule called Jieyu Chufan can safely and effectively reduce symptoms of depression. It may be a good option if you have moderate to severe depression and haven't taken antidepressants in the last 2 weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
480 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between the ages of 18 and 65.
  • You have been diagnosed with depression (first episode or relapse).
  • Your depression score on the HAMD-17 scale is 18 or higher (moderate to severe).
  • You have not taken any antidepressants for at least 2 weeks (or 6 weeks for a medicine called fluoxetine/Prozac).
  • You are willing to sign a consent form to participate.
  • You do not have other major mental health conditions, severe physical illnesses, or a high risk of suicide.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06793397Recruiting· Phase 3
Study of an experimental psychedelic-like drug for depression (CYB003)

This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.

Birmingham, Alabama
NCT07741240Not yet recruiting· Phase 3
New antidepressant study for adults with major depression

This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can safely and effectively reduce depression symptoms.

NCT07621237Recruiting· Phase 2
TNX-102 SL for Major Depressive Disorder

This study tests whether a new medication called TNX-102 SL can reduce depression symptoms better than a placebo (inactive pill). You'll take the medication daily and have regular check-ins to see how you're doing.

Phoenix, Arizona
NCT06827431Not yet recruiting· Phase 3
Testing ammoxetine for depression

This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.

NCT07602153Not yet recruiting
Study of medications for depression with suicidal thoughts

This research study tests different medication approaches for people with major depression who are having thoughts of suicide. The goal is to understand which treatments work best and why, so doctors can help patients more effectively.

NCT07785284Not yet recruiting
Shugan Jieyu capsules for depression relief

This study tests whether a traditional Chinese medicine called Shugan Jieyu capsules can safely and effectively reduce symptoms of depression. It's an observational, real-world trial, so it follows how the treatment works in everyday life rather than in a strictly controlled lab setting.

Beijing

Hear when a new Major Depressive Disorder (MDD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.